ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
71.085,00
-0,51%
Brent Oil
82,515
-1,22%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. NewLink Genetics Corporation (NLNK)

  7. NewLink Genetics Corporation (NLNK) Notícias

NLNK

NewLink Genetics (NLNK)

NewLink Genetics Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NLNK
DataHoraFonteTítuloCódigoCompanhia
09/06/202018:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NLNKNewLink Genetics Corporation
02/06/202018:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NLNKNewLink Genetics Corporation
01/06/202007:29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:NLNKNewLink Genetics Corporation
29/04/202017:15Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NLNKNewLink Genetics Corporation
07/04/202018:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NLNKNewLink Genetics Corporation
07/04/202017:45Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NLNKNewLink Genetics Corporation
01/04/202007:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NLNKNewLink Genetics Corporation
30/03/202019:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NLNKNewLink Genetics Corporation
30/03/202009:00GlobeNewswire Inc.Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the BoardNASDAQ:NLNKNewLink Genetics Corporation
18/03/202009:00GlobeNewswire Inc.NewLink Genetics Stockholders Approve Merger with Lumos PharmaNASDAQ:NLNKNewLink Genetics Corporation
06/03/202010:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NLNKNewLink Genetics Corporation
03/03/202018:28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NLNKNewLink Genetics Corporation
28/02/202011:00GlobeNewswire Inc.NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:NLNKNewLink Genetics Corporation
18/02/202012:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NLNKNewLink Genetics Corporation
14/02/202017:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NLNKNewLink Genetics Corporation
13/02/202018:39Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:NLNKNewLink Genetics Corporation
10/02/202010:32Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NLNKNewLink Genetics Corporation
04/02/202010:04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NLNKNewLink Genetics Corporation
23/12/201918:05GlobeNewswire Inc.NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commer...NASDAQ:NLNKNewLink Genetics Corporation
20/12/201912:09GlobeNewswire Inc.NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®)NASDAQ:NLNKNewLink Genetics Corporation
16/12/201910:00GlobeNewswire Inc.NewLink Genetics Responds to Proposal from EvercelNASDAQ:NLNKNewLink Genetics Corporation
13/12/201911:12Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:NLNKNewLink Genetics Corporation
12/12/201919:31GlobeNewswire Inc.Evercel Announces Rejected Offer to Acquire NewLink GeneticsNASDAQ:NLNKNewLink Genetics Corporation
20/11/201908:39Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:NLNKNewLink Genetics Corporation
12/11/201911:00GlobeNewswire Inc.NewLink Genetics Announces European Commission Grant of Conditional Marketing Approval for Ebola Vaccine V920 (ERVEBO®)NASDAQ:NLNKNewLink Genetics Corporation
06/11/201910:00GlobeNewswire Inc.NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:NLNKNewLink Genetics Corporation
30/10/201909:30GlobeNewswire Inc.NewLink Genetics to Host Its Third Quarter 2019 Conference Call on November 6, 2019NASDAQ:NLNKNewLink Genetics Corporation
21/10/201917:30GlobeNewswire Inc.NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Va...NASDAQ:NLNKNewLink Genetics Corporation
30/09/201917:35GlobeNewswire Inc.NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapi...NASDAQ:NLNKNewLink Genetics Corporation
17/09/201918:05GlobeNewswire Inc.NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vac...NASDAQ:NLNKNewLink Genetics Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:NLNK

Seu Histórico Recente

LSE
JRG
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados